A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis

BACKGROUND: The B cell chemoattractant CXCL13 is a promising biomarker in rheumatoid arthritis (RA), with a plausible role in supporting diagnosis, monitoring disease activity and as a prognostic value. It is a key chemokine driving the formation of lymphoid follicles within the inflamed synovium. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Bechman, Katie, Dalrymple, Anthony, Southey-Bassols, Charles, Cope, Andrew P., Galloway, James B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604968/
https://www.ncbi.nlm.nih.gov/pubmed/33292827
http://dx.doi.org/10.1186/s41927-020-00154-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604968/
https://www.ncbi.nlm.nih.gov/pubmed/33292827
http://dx.doi.org/10.1186/s41927-020-00154-3

Ejemplares similares